Beranda › Kanker Paru Non-Sel Kecil › Maryland › Germantown
Uji klinis Kanker Paru Non-Sel Kecil di Germantown, MD
17 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Germantown (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Menerima pesertaFase 1/2
- Virgnia Cancer Specialists /ID# 269633, Leesburg · 16 mi jauhnya
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi jauhnya
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Menerima pesertaFase 3
- Maryland Oncology Hematology (MOH) ( Site 8102), Rockville · 9 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Maryland Oncology Hematology P.A., Germantown
- Maryland Oncology Hematology PA, Rockville · 9 mi jauhnya
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Frederick · 18 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Maryland Oncology Hematology, P.A., Germantown
- Maryland Oncology Hematology, P.A., Rockville · 9 mi jauhnya
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- James M Stockman Cancer Institute, Frederick · 18 mi jauhnya
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Menerima pesertaFase 3
- Research Site, Leesburg · 16 mi jauhnya
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Menerima pesertaFase 2/3
- Frederick Health Hospital- James M Stockman Cancer Institute, Frederick · 18 mi jauhnya
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Menerima pesertaFase 2/3
- Local Institution - 007-814-C, Leesburg · 16 mi jauhnya
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- Inova Loudoun Hospital, Leesburg · 16 mi jauhnya
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- USOR Maryland Oncology Hematology, Rockville · 9 mi jauhnya
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Menerima pesertaStudi observasional
- Frederick Health Hospital, Frederick · 18 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi jauhnya
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Frederick Health Regional System, Frederick · 18 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Germantown
- Skizofrenia11 studi
- Kanker Payudara10 studi
- Kanker Paru9 studi
- Kanker (semua jenis)7 studi
- Depresi7 studi
- Obesitas7 studi
- Diabetes Tipe 27 studi
- Penyakit Kardiovaskular6 studi
- Kanker Kandung Kemih6 studi
- Kelebihan Berat Badan5 studi
- Gangguan Depresi Mayor5 studi
- Tekanan Darah Tinggi4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.